MARKET

COEPW

COEPW

Coeptis Therapeutics Holdings Inc
NASDAQ
0.0095
-0.0015
-13.64%
Opening 10:56 04/10 EDT
OPEN
0.0109
PREV CLOSE
0.0110
HIGH
0.0109
LOW
0.0095
VOLUME
32.38K
TURNOVER
--
52 WEEK HIGH
0.0454
52 WEEK LOW
0.0042
MARKET CAP
--
P/E (TTM)
-0.0034
1D
5D
1M
3M
1Y
5Y
1D
Coeptis Wins Nasdaq Nod for Z Squared Merger Listing
TipRanks · 2d ago
Coeptis says Nasdaq approves post-merger listing on Global Market as ZSQR
Reuters · 2d ago
Coeptis Therapeutics Announces Nasdaq Grants Approval For Post-Merger Listing Under 'ZSQR' Ticker; Coeptis-Z Squared Merger Expected To Close Q2 2026
Benzinga · 2d ago
*Coeptis Therapeutics: Z Squared to List on Nasdaq Under ZSQR, Effective Upon Merger Close
Dow Jones · 2d ago
*Coeptis Therapeutics Sees Z Squared Deal Closing in 2Q >COEP
Dow Jones · 2d ago
*Coeptis: Z Squared Nasdaq Listing Application Approved
Dow Jones · 2d ago
COEPTIS ANNOUNCES APPROVAL OF Z SQUARED INC.’S NASDAQ LISTING APPLICATION
Reuters · 2d ago
Press Release: Coeptis Announces Approval of Z Squared Inc.'s Nasdaq Listing Application
Dow Jones · 2d ago
More
About COEPW
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, including Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc. and Coeptis Pharmaceuticals, LLC., is a biopharmaceutical company. The Company owns, acquires, and develops cell therapy technologies for cancer and other diseases. Its product portfolio and rights are highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen chimeric antigen receptor (CAR) T technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms, which the Company is developing with VyGen-Bio and medical researchers at the Karolinska Institute. Its CAR therapy is a treatment for cancer in which a patient's T cells are genetically engineered to recognize cancer cells to target and destroy them.

Webull offers Coeptis Therapeutics Holdings Inc stock information, including NASDAQ: COEPW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COEPW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COEPW stock methods without spending real money on the virtual paper trading platform.